One of the biggest myths I still hear is: “Once you’re older, your brain no longer makes new neurons.” That idea has been challenged for years, and the newest human data pushes back even harder. In the February 2026 Nature paper by Disouky and colleagues, human postmortem hippocampal tissue from young adults, cognitively normal older adults, SuperAgers, and adults with Alzheimer’s disease showed that hippocampal neurogenesis persists into later life, although it declines with aging and is markedly impaired in Alzheimer’s disease.[1] That matters because the hippocampus is central to memory formation, pattern separation, and cognitive resilience. The message is hopeful: aging does not automatically mean the end of hippocampal neurogenesis.
The 2026 Nature study is not an isolated finding. Earlier human work also reported persistent hippocampal neurogenesis into advanced age, even into the eighth through tenth decades, though at reduced levels and with major person-to-person variability.[2] Recent reviews now describe adult hippocampal neurogenesis as a real, biologically meaningful form of plasticity in the adult and aging human brain, while also emphasizing that healthy aging and Alzheimer’s disease diverge sharply in the quality of the neurogenic niche.[3,4] In plain English, older brains can still generate new neurons, but whether they do so well depends heavily on the metabolic, inflammatory, vascular, and trophic environment surrounding those stem cells.
That does not mean we can claim that supplements “treat Alzheimer’s disease.” We should be very careful there. The more accurate and scientifically responsible statement is this: the literature supports a model in which preserving metabolic health, reducing neuroinflammation, supporting mitochondrial function, improving cerebral perfusion, and correcting nutrient insufficiencies may help optimize brain function and may help maintain a brain environment more favorable to neurogenesis and cognitive resilience.[1,3-5] In other words, we are addressing dysfunction and optimizing physiology, not claiming to cure disease.
Why Neurogenesis Matters in Cognitive Aging
Adult hippocampal neurogenesis is most closely tied to the dentate gyrus. This region helps the brain encode new memories and distinguish one memory from another. Human and translational studies increasingly suggest that reduced neurogenesis tracks with worse cognitive status, while preserved neurogenesis is associated with healthier brain aging.[1-4] The 2026 Nature study is especially interesting because “SuperAgers” showed a more favorable neurogenic profile than typical older adults and those with Alzheimer’s pathology, reinforcing the idea that robust hippocampal plasticity is part of cognitive resilience rather than a youthful phenomenon that simply disappears.[1]
What Drives Neurogenesis Down?
Aging alone reduces the rate of neurogenesis, but it does not eliminate it.[1-4] The bigger problems appear to be chronic neuroinflammation, insulin resistance, poor vascular signaling, mitochondrial dysfunction, oxidative stress, sleep disruption, and the cumulative burden of unhealthy lifestyle patterns.[3-6] This is where many patients get into trouble. They are not simply “getting older.” They are aging inside an inflammatory, insulin-resistant, undernourished, and often sedentary physiological environment.
Insulin signaling is especially important. Reviews on brain insulin resistance describe insulin as a regulator of hippocampal plasticity and adult neurogenesis, and experimental work shows that hippocampal insulin resistance reduces immature neurons and disrupts dendritic architecture.[5,6] Diabetes and insulin resistance have repeatedly been linked to impaired hippocampal neurogenesis, synaptic dysfunction, and memory decline in preclinical models.[7,8] That is one reason I continue to emphasize fasting insulin, glycemic control, and metabolic health. When insulin signaling is poor, the brain’s trophic and repair environment is poorer as well.
Inflammation is another major suppressor. Chronic peripheral and central inflammation can inhibit hippocampal neurogenesis and may contribute to behavioral and cognitive decline.[9] In Alzheimer’s disease specifically, adult hippocampal neurogenesis appears to fall early, and the neurogenic niche becomes progressively more hostile.[4] Neuroinflammation, oxidative stress, amyloid-related toxicity, vascular dysfunction, and mitochondrial injury all push the system in the wrong direction.
Diet quality matters too. Recent meta-analyses and prospective studies support lower dementia risk with Mediterranean-style dietary patterns, and higher risk with greater ultra-processed food intake.[10-13] I would frame this clinically as a whole-foods, lower-glycemic, insulin-sparing pattern: real food, higher nutrient density, adequate protein, healthy fats, fiber, and fewer refined carbohydrates and ultra-processed foods. That is not because one diet “treats Alzheimer’s,” but because blood sugar volatility, hyperinsulinemia, and diet-driven inflammation create a less favorable environment for neuronal resilience and neurogenesis.[5-13]
What Appears to Support Neurogenesis and Brain Resilience?
The strongest lifestyle evidence is probably exercise. In older adults, aerobic exercise has been shown to increase anterior hippocampal volume by about 2% over one year, partially reversing age-related loss, and this change was associated with higher Brain-Derived Neurotrophic Factor (BDNF), a key neurotrophic signal involved in neurogenesis.[14] More recent reviews continue to support exercise as a practical intervention for supporting hippocampal plasticity, cognition, and a more neurogenesis-friendly environment in aging brains.[15,16]
Sleep also matters. Experimental and review data show that sustained sleep disruption suppresses hippocampal cell proliferation and neurogenesis, and worse sleep is associated with greater hippocampal atrophy across adulthood.[17,18] Patients often want the “best supplement for memory,” while ignoring the fact that fragmented sleep itself works against the very biology they are trying to restore.
A Functional-Medicine Framing
From a functional-medicine standpoint, the goal is not to claim that a nutrient or formula cures dementia. The goal is to identify and improve the physiological terrain that supports brain function: blood flow, mitochondrial output, inflammatory balance, methylation status, glycemic control, membrane integrity, and trophic signaling.[5,9-18] That is why stacking can make sense. Neurodegeneration is multifactorial, so support often has to be multifactorial as well.
BIOSPEC STACKING STRATEGY FOR OPTIMIZING BRAIN FUNCTION
1. AD-FOCUS HP: Perfusion, neurotransmission, and neuronal support*
BioSpec describes AD-FOCUS HP as a cognition support formula featuring Bacopa monnieri, Ginkgo biloba, Huperzine A, and vinpocetine.[19] Mechanistically, that stack makes sense for cognitive support. Bacopa has human data for memory-related outcomes and preclinical data suggesting effects on BDNF-related signaling and hippocampal neurogenesis.[20,21] Ginkgo has evidence for supporting cerebral blood flow and may benefit certain domains of cognition, although dementia-prevention data are mixed rather than uniformly positive.[22-24] Huperzine A has cholinergic and neuroprotective properties in the literature, including anti-inflammatory, mitochondrial, and synaptic mechanisms, though clinical evidence remains limited and heterogeneous.[25,26] Vinpocetine has been studied for cerebral blood flow, neuronal metabolism, and neuroprotection, with stronger mechanistic than definitive Alzheimer’s-prevention data.[27,28]
So how should this be said responsibly? AD-FOCUS HP may help support focus, perfusion, cholinergic signaling, antioxidant defense, and neuronal resilience.* The evidence for directly enhancing human hippocampal neurogenesis is suggestive but not proven; most of that signal is still preclinical or indirect. That is still useful, but it should be presented honestly.
2. MITO-DETOX III: Mitochondrial support and oxidative-stress control*
BioSpec’s MITO-DETOX III includes NAC, acetyl-L-carnitine, silymarin, R-alpha-lipoic acid, CoQ10, NADH, PQQ, and selenium.[29] This is a strong “cellular energy and oxidative-stress” stack. That matters because neural stem cells and maturing neurons are highly sensitive to mitochondrial health, redox balance, and inflammatory stress.[3,15] Several ingredients in this formula have plausible relevance to brain resilience*: NAC for glutathione support and oxidative-stress buffering, acetyl-L-carnitine for mitochondrial transport and neuronal energetics, alpha-lipoic acid and CoQ10 for redox and mitochondrial support, PQQ for mitochondrial biogenesis signaling, and NADH for cellular energy metabolism.[29]
Here again, the clean claim is not “this treats neurodegeneration.” The cleaner claim is that MITO-DETOX III may help optimize mitochondrial function and reduce oxidative burden in a way that supports healthier neuronal physiology. Direct human evidence that this exact combination increases neurogenesis is limited, but the biological rationale is strong.
3. FISH OIL / SUPER OMEGA PLUS: Membrane integrity, inflammation control, and neuroplasticity support*
DHA is structurally important to neuronal membranes, synapses, and signaling, and omega-3 fatty acids have long been studied for neuroplasticity and neurogenesis.[30,31] Reviews describe DHA-rich omega-3 status as supportive of hippocampal neurogenesis, dendritic spine formation, synaptic plasticity, and neuroprotection.[30-32] Clinical outcomes in Alzheimer’s disease are mixed, but the mechanistic case for omega-3 support in brain aging remains strong, especially earlier in the dysfunction process rather than very late disease.[31,32]
BioSpec’s Super Omega Plus provides 600 mg combined EPA/DHA per softgel.[33] For a functional brain-support target, a reasonable evidence-aligned range is often around 1.2 to 2.4 grams daily of combined EPA+DHA, which would translate to roughly 2 to 4 softgels daily of this product, depending on the clinical situation and the rest of the diet.[30-33] In practice, I would individualize that based on diet, inflammatory burden, triglycerides, omega-3 intake, and medication interactions, especially with anticoagulants.
4. INFLAM-95: Lowering inflammatory tone so the brain can function better*
BioSpec describes Inflam-95 as a blend centered on curcuminoids, Boswellia, ginger, nettle, and piperine, with the current product copy emphasizing standardized 95% curcuminoids and enhanced absorption with BioPerine.[34] Curcumin has substantial mechanistic literature in neuroinflammation, and preclinical work suggests it can improve neurogenesis-related signaling in Alzheimer’s models.[35,36] Boswellia presents an anti-inflammatory and possibly cognition-supportive effect, with some newer human data suggesting favorable effects on cognition-related outcomes and BDNF, although this is still an emerging area rather than settled proof.[37]
This is important clinically because inflammation does not just make people hurt; it also makes neurons and neural stem cells function poorly. An anti-inflammatory stack may therefore help create a more permissive environment for plasticity and function. Again, that is a claim about optimizing physiology and dampening dysfunction, not treating Alzheimer’s disease itself.
5. METHYL-EASE HP: Homocysteine and methylation support*
Methyl-Ease HP contains bioavailable B vitamins including riboflavin-5-phosphate, methylfolate, folinic acid (5-formyltetrahydrofolate), methylcobalamin, and pyridoxal-5-phosphate.[38] This is highly relevant when homocysteine is elevated. In the VITACOG trial, homocysteine-lowering B-vitamin therapy in people with mild cognitive impairment slowed the rate of brain atrophy, and subsequent analyses reported cognitive and clinical benefits in subgroups, especially when omega-3 status was favorable.[39,40] More recent analyses continue to support the importance of homocysteine lowering in brain aging.[41]
So, if a patient shows elevated homocysteine, impaired methylation capacity, or low functional B-vitamin status, a methylation-support stack is not about “treating dementia.” It is about removing a known metabolic stressor that is associated with brain atrophy and cognitive decline.
6. GLUCOSE-IR: Reducing the metabolic terrain that works against neurogenesis*
BioSpec’s Glucose-IR includes mulberry leaf, berberine, cinnamon extract, biotin, and chromium.[42] Those ingredients are directed at insulin signaling and glycemic control, which makes good physiologic sense in any brain-support program where fasting insulin, glucose variability, triglycerides, or broader insulin resistance are concerns. The company’s product information specifically highlights cinnamon, mulberry, berberine, biotin, and chromium for insulin and glucose metabolism support.*[42,43]
Why does that matter for the brain? Because insulin resistance and diabetes are repeatedly linked with impaired hippocampal plasticity, reduced neurogenesis, neuroinflammation, and cognitive decline.[5-8] If you improve insulin signaling and reduce glycemic burden, you are likely improving the terrain in which the hippocampus has to function. That is the appropriate functional-medicine claim.
PRACTICAL CLINICAL TAKEAWAYS
First, the older brain is not biologically static. Human hippocampal neurogenesis appears to persist through later decades of life, though it declines with age and falls further in Alzheimer’s disease.[1-4]
Second, the most honest interpretation of the literature is not “we can promise prevention.” The honest interpretation is that a healthier neurogenic niche is associated with better cognitive aging, and that many modifiable factors that suppress neurogenesis are the same ones already linked to dementia risk: inactivity, diabetes, poor diet quality, vascular dysfunction, inflammation, and related metabolic stressors.[5-18] The 2024 Lancet Commission estimated that about 45% of dementia cases may be potentially preventable or delayable by addressing 14 modifiable risk factors across the life course.[44]
Third, a rational supportive program should be layered. A whole-foods, lower-glycemic dietary pattern; exercise; sleep repair; omega-3 support; inflammatory control; methylation support when homocysteine is elevated; and insulin-sensitizing support when labs show resistance all fit the biology.[5-18,30-44] That is why stacking makes sense. Neurocognitive decline is rarely driven by one single variable.
Fourth, I would state very plainly to patients and practitioners: these interventions are designed to optimize function, improve terrain, and support healthy physiology. They are not substitutes for diagnosis or medical treatment of Alzheimer’s disease or other dementias. That language is both scientifically fair and clinically responsible.
†Biospec Nutritionals — Medical & Educational Disclaimer
This content is provided for educational and informational purposes only and is not intended to provide medical advice, diagnosis, or treatment. It is not a substitute for individualized guidance from a qualified healthcare professional. Always consult your physician or other qualified healthcare provider before starting, stopping, or changing any supplement, medication, diet, or exercise program.
*FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
References